Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid
A McAllister, H Mosberg, J A Settlage, J A Steiner, A McAllister, H Mosberg, J A Settlage, J A Steiner
Abstract
Twenty-four healthy male subjects participated in a study comparing plasma concentrations of nitroglycerin generated by single applications of Nitradisc 32 mg, Transiderm-Nitro 50 mg and Nitro-Dur 104 mg patches and from one inch of Nitrobid 2% ointment. The three patch preparations are designed to release 10 mg nitroglycerin systemically over a 24 h period. Nitrobid ointment is intended to deliver 15 mg nitroglycerin per inch of ointment, and to be reapplied at least every 8 h. Blood was taken for nitroglycerin assay up to and including 24 h after each application. Assay for nitroglycerin was performed using a gas chromatography-mass spectrometry technique. Plasma concentrations of nitroglycerin were sustained up to the 24 h mark with all three patch preparations, but not with application of Nitrobid ointment. Nitrobid was associated with a rapid rise in nitroglycerin plasma concentrations maximal 1 h after application. Plasma concentrations of nitroglycerin absorbed from Nitrobid ointment fell below those absorbed from all three patch preparations after 8 h. Clinically, all four formulations were similar with respect to side effects, with headache and dizziness being the most common.
References
- Br Heart J. 1976 Oct;38(10):1031-6
- Circulation. 1979 Mar;59(3):585-8
- J Pharm Sci. 1981 Dec;70(12):1368-9
- Anesth Analg. 1982 Jun;61(6):541-3
- Lancet. 1984 Jun 9;1(8389):1297
- Am J Hosp Pharm. 1982 Jun;39(6):1018-21
- Acta Med Scand. 1983;213(3):165-70
- Clin Pharmacokinet. 1983 Sep-Oct;8(5):410-21
- Arzneimittelforschung. 1983;33(12):1677-9
- JAMA. 1982 Jul 23;248(4):427
Source: PubMed